SpringWorks Therapeutics Enters into Research Collaboration with Leading Cancer Institute to Further Evaluate Nirogacestat as a BCMA Potentiator in Multiple Myeloma

NEXT STORY
Renalytix Appoints Daniel J. Levangie to its Board of Directors
PREV STORY
Global Microbiome Landscape Market Study 2021: Growing Research and Skyrocketing Venture Funding
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Iovance Biotherapeutics Enters into a Research Collaboration Focused on Hematologic Malignancies with The Ohio State University Comprehensive Cancer Center

SAN CARLOS, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a ...

author_avatar
NASDAQ Market News

Altimmune Restructures Financing Agreement

GAITHERSBURG, Md., June 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics ...

author_avatar
NASDAQ Market News

Biocartis Group NV: Results of the annual shareholders’ meeting held on 11 May 2018

PRESS RELEASE: REGULATED INFORMATION11 May 2018, 17:40 CEST                                                            Results of the annual shareholders' ...

author_avatar
NASDAQ Market News